Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 54346-87-1 | MDL No. : | MFCD00464314 |
Formula : | C8H8N2OS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OMIHQJBWAPWLBO-UHFFFAOYSA-N |
M.W : | 180.23 | Pubchem ID : | 41055 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 50.52 |
TPSA : | 76.38 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.98 cm/s |
Log Po/w (iLOGP) : | 1.84 |
Log Po/w (XLOGP3) : | 2.0 |
Log Po/w (WLOGP) : | 1.9 |
Log Po/w (MLOGP) : | 0.97 |
Log Po/w (SILICOS-IT) : | 2.38 |
Consensus Log Po/w : | 1.82 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.71 |
Solubility : | 0.354 mg/ml ; 0.00197 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.23 |
Solubility : | 0.106 mg/ml ; 0.000588 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.74 |
Solubility : | 0.33 mg/ml ; 0.00183 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.08 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74.64% | for 4 h; Reflux | Hydrobromic acid (208.60 g, 1.3 mol) was added to a 250 ml round bottom flask equipped with a mechanicalstirrer over 15 minutes, and then 2-amino-5-methoxybenzothiazole (17 g, 94.32 mmol) was added thereto. The mixturewas heated and refluxed for 4 hours, then cooled to 0-5 °C until a solid precipited, then stirred for half an hour at 0-5 °Cand then the suction filtration under reduced pressure was performed. The solid was transferred to a 1 L round bottomflask and slowly added with saturated sodium carbonate solution under mechanical stirring to adjust till the pH was 6.5to 7, and then stirred at room temperature for 0.5 hour, filtered and the filter cake was washed with 300 ml of water, andthen dried under vacuum at 50 °C to give a gray compound 161A as solid (11.7 g, the yield was 74.64percent).1H NMR (400MHz, DMSO-d6) = 9.11 (s, 1H), 7.15 (s, 1H), 7.12 (s, 2H), 7.03 (d, J=2.3 Hz, 1H), 6.65 (dd, J=2.3, 8.5 Hz, 1H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With bromine In dichloromethane; chloroform at 20℃; for 4 - 6 h; Heating / reflux | I. N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[6-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea hydrochloride [Compound B12] was also prepared by first preparing the benzothiazole starting material, 5 methoxy-benzothiazol-2-yl-amine: To prepare the 5-methoxy-benzothiazol-2-ylamine starting material: To a suspension of (3-methoxy-phenyl)-thiourea (1.822 g, 10 mmol) in CH2Cl2 (20 mL) at 0 C. was added dropwise a solution of bromine (1.76 g, 11 mmol) in 10 ml of trichloromethane over a period of thirty minutes. The reaction was stirred for 3 hours at room temperature then heated to 3 hours to reflux for one hour. The precipitate was filtered and washed with dichloromethane. The solid was suspended in saturated NaHCO3 and extracted with CH2Cl2. The extract was dried over MgSO4 and concentrated to give a white solid (1.716 g, 95percent). To prepare the 2-amino-benzothiazol-5-ol: To a suspension of 5-methoxy-benzothiazol-2-ylamine in 16 mL of 48percent HBr/H2O was heated to 105 C. in an oil bath for 10 hours. After the reaction was cooled to room temperature, the precipitate was collected by filtration and washed with acetone. The filtrate was suspended in saturated NaHCO3 and extracted with CH2Cl2. The extract was dried over MgSO4 and concentrated to give a white solid (0.986 g, 63percent). N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[6-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea hydrochloride 2-amino-benzothiazol-5-ol from the previous step and following the method described in 1H NMR (DMSO-d6) ? 11.1 (br, 1H), 9.69 (br, 1H), 9.28 (br, 1H), 8.71 (s, 1H), 7.97 (d, 1H), 7.79 (d and s, 3H), 7.56 (d, 2H), 7.13 (dd, 1H), 6.53 (s, 1H), 4.56 (t, 2H), 3.98 (m, 2H), 3.82 (t, 2H), 3.65 (m, 2H), 3.55 (m, 2H), 3.25 (m, 2H), 1.31 (s, 9H); LC-MS: ESI 561 (M+H)+. [Compound B12] |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77.3% | With tert.-butylnitrite In tetrahydrofuran at 60℃; | 5-methoxybenzo [d] thiazol-2-amine (397 mg, 2.2 mmol) was dissolved in THF (16 ml). There to tertiary-butyl nitrite (0.375 ml, 3.17 mmol) was stirred overnight at 60 added. After the reaction, the solvent was evaporated. The residue was purified by silica gel column chromatography (SNAP 10g, hexane / ethyl acetate) to give the title compound (281 mg, 77.3percent) as a yellow solid. |
[ 65948-19-8 ]
6-Phenoxybenzo[d]thiazol-2-amine
Similarity: 0.96
[ 6294-52-6 ]
5,6-Dimethoxybenzo[d]thiazol-2-amine
Similarity: 0.96
[ 5464-79-9 ]
2-Amino-4-methoxybenzothiazole
Similarity: 0.83
[ 65948-19-8 ]
6-Phenoxybenzo[d]thiazol-2-amine
Similarity: 0.96
[ 6294-52-6 ]
5,6-Dimethoxybenzo[d]thiazol-2-amine
Similarity: 0.96
[ 5464-79-9 ]
2-Amino-4-methoxybenzothiazole
Similarity: 0.83